Unite to Fight the Flu – Influenza Season UpdateThere is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus, and the…
Myasthenia gravis: An updateLearn more about this common disorder of neuromuscular transmission and its affects on patients
FDA seeks advice on metal-on-metal hip replacementsOn March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement systems will…
FDA approves first quadrivalent vaccine to prevent seasonal influenzaOn Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain four strains…
FDA announces agreement in principle on medical device user feesOn Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in principle on…
FDA announces guidelines for polymyxin, vecuronium recallOn Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled because of…
U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate because of…
FDA approves expanded use of Prevnar vaccineThe U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50 years and…
New minimally invasive technique treats acute DVTPharmacomechanical thrombectomy removes dangerous clots to restore healthy function in hours.
FDA approves first generic version of LipitorThe U.S. Food and Drug administration has approved the first generic version of Lipitor (atorvastatin calcium). Read more.
ECRI names top 10 health technology hazards for 2012ECRI Institute’s top 10 health technology hazards for 2012 include alarm hazards, medication errors when using infusion pumps, enteral feeding misconnections, and cross-contamination from…
Unite to Fight the Flu – Influenza Season UpdateThere is a saying that if you’ve experienced one influenza season, you’ve experienced one influenza season. Influenza is a highly unpredictable virus,…
Myasthenia gravis: An updateLearn more about this common disorder of neuromuscular transmission and its affects on patients
FDA seeks advice on metal-on-metal hip replacementsOn March 29, the U.S. Food and Drug Administration (FDA) announced that a two-day expert advisory panel meeting on metal-on-metal hip replacement…
FDA approves first quadrivalent vaccine to prevent seasonal influenzaOn Feb. 29, the U.S. Food and Drug Administration (FDA) announced the approval of FluMist Quadrivalent, the first influenza vaccine to contain…
FDA announces agreement in principle on medical device user feesOn Feb. 1, The U.S. Food and Drug Administration (FDA) and medical device industry representatives announced they had reached an agreement in…
FDA announces guidelines for polymyxin, vecuronium recallOn Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled…
U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate…
FDA approves expanded use of Prevnar vaccineThe U.S. Food and Drug Administration (FDA) has approved the use of Prevnar 13, a pneumococcal 13-valent conjugate vaccine, in people 50…
New minimally invasive technique treats acute DVTPharmacomechanical thrombectomy removes dangerous clots to restore healthy function in hours.
FDA approves first generic version of LipitorThe U.S. Food and Drug administration has approved the first generic version of Lipitor (atorvastatin calcium). Read more.
ECRI names top 10 health technology hazards for 2012ECRI Institute’s top 10 health technology hazards for 2012 include alarm hazards, medication errors when using infusion pumps, enteral feeding misconnections, and…
